• Latest NORD Webinar Offers Insights on Starting Nonprofit, Patient Registry
  • My Diagnosis Was Gut-wrenching, but Life Gets Better
  • Lenabasum Eases Pulmonary Decline in dcSSc Patients on Long-term Immunosuppressants, Trial Finds
  • Long-term Ofev Safely Slows Lung Function Decline in SSc-ILD Patients, Trial Data Show
  • Can Someone Pass Me Life’s Handbook?
  • Learning How to Recharge After Trauma
  • Ofev Slows Disease Progression in SSc-ILD, Data Shows, Supporting Therapy’s Benefits
  • Galectin-3 Protein May Be Blood Biomarker for Scleroderma and Like Diseases
  • NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits
  • Genetic Profile Models Show Potential to Predict Person’s Scleroderma Risk
  • High Levels of S100A12 Protein May Increase Severity of Scarring, ILD, Study Suggests
  • Overall Health Benefits Found With Abatacept in dcSSc Patients After 18 Months